Medifast, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $169.7M |
| Cost of Revenue | $45.4M |
| Gross Profit | $124.4M |
| Gross Margin | 73.3% |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $105.9M |
| Operating Income | $18.5M |
| Operating Margin | 10.9% |
| Interest Expense | $145.0K |
| Pretax Income | $18.4M |
| Income Tax Expense | $7.1M |
| Net Income | $11.4M |
| Net Margin | 6.7% |
| EPS (Basic) | $0.84 |
| EPS (Diluted) | $0.77 |
| Shares Outstanding (Basic) | 13.5M |
| Shares Outstanding (Diluted) | 14.7M |
| Dividends Per Share | — |